First Bank & Trust Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

First Bank & Trust lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,202 shares of the medical equipment provider’s stock after selling 230 shares during the quarter. First Bank & Trust’s holdings in Intuitive Surgical were worth $3,759,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. M.E. Allison & CO. Inc. purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $82,517,000. Sycomore Asset Management raised its position in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC raised its position in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. raised its position in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock worth $3,587,582 over the last 90 days. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Up 1.3 %

Shares of ISRG stock opened at $608.48 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a market cap of $216.73 billion, a P/E ratio of 94.93, a PEG ratio of 5.74 and a beta of 1.39. The firm has a fifty day moving average price of $563.17 and a 200 day moving average price of $522.88.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Raymond James boosted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. boosted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Barclays boosted their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.